CompletedNot Applicable

Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content

United States207 participantsStarted 2015-08-12

Plain-language summary

The purpose of this multi-site research is to validate a rapid magnetic resonance based confounder-corrected R-2 mapping method as a quantitative imaging biomarker of liver iron concentrations.

Who can participate

Age range8 Years – 89 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * know or suspected iron overload * minimum age: Stanford- 8years , University of Wisconsin - 10 years, John Hopkins follow- 10 years, University of Texas-Southwestern - 18 years Exclusion Criteria: * contraindication to magnetic resonance imaging

What they're measuring

Calibration curve of liver R2* vs LIC measured by Ferriscan at each of the sites

Timeframe: 1 year

Trial details

NCT IDNCT02025543

SponsorUniversity of Wisconsin, Madison

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-09

View on ClinicalTrials.gov More Iron Overload trials